
Cornerstone Brands plans to acquire payments processor FXPress in a deal that also includes a sale of the existing Cornerstone business and restructuring of capital, according to a press release emailed to PYMNTS.
FXPress provides advanced payment systems through a Platform-as-a-Service agreement. The new company strategy will involve building a business off providing international payment services for small- to medium-sized businesses (SMBs) through both “organic and inorganic growth,” the release stated.
According to the release, the company directors want to capitalize on what they see as an opportunity to develop a wider range of products and services. They want to allow customers to maintain their own multicurrency electronic payment accounts, attracting larger SMB customers and growing in-house sales capacity.
Cornerstone’s directors were “excited by FXPress’ strategy to develop its business and be a true disrupter in the market by enabling [SMBs] to make efficiency gains in the way they conduct international payments.”
“The global payments landscape is in a state of fundamental transformation, with immense opportunities for technology-led businesses such as FXPress,” the release stated.
The deal went down for over 99 percent of shares cast in favor of it, the release stated. In addition, Cornerstone Brands’ existing business will be sold to Oliver Bridge and Spencer Hill after the FXPress acquisition is complete. Existing Cornerstone shareholders will receive funds if another sale occurs within the next few years.
Featured News
Fortnite Returns to Apple’s U.S. App Store After Five-Year Ban
May 21, 2025 by
CPI
Federal Court to Hear Case on Trump’s Firing of FTC Democrats
May 20, 2025 by
CPI
UK Government Suffers Third Successive Defeat on Data (Use and Access) Bill
May 20, 2025 by
CPI
Sex Toy Retailer Says Google Breaches EU Digital Market Rules
May 20, 2025 by
CPI
Latham & Watkins Expands Brussels Antitrust Team
May 20, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas